← Back to Search

Exercise Timing for Type 2 Diabetes

N/A

Recruiting

Led By Steven K Malin, PhD

Research Sponsored by Rutgers, The State University of New Jersey

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Subjects currently taking medications that affect heart rate and rhythm (i.e. Ca++ channel blockers, nitrates, alpha- or beta-blockers)

Male or female >30 and <70 years old

Must not have

Evidence of type 1 diabetes and diabetics requiring insulin therapy

Currently taking active weight suppression medication (e.g. phentermine,orlistat, lorcaserin, naltrexone-bupropion in combination, liraglutide, benzephetamine, diethylpropion, phendimetrazine)

Timeline

Screening 3 weeks

Treatment Varies

Follow Up over the course of 2 weeks.

Awards & highlights

No Placebo-Only Group

Summary

This trial will test whether Noom, a weight-loss app, helps people with type 2 diabetes better stick to their exercise and diet plan, leading to more weight loss and better health.

Who is the study for?

Adults aged 30-70 with type 2 diabetes, a BMI between 28 and 45, not currently on weight loss meds or insulin therapy. Mustn't have significant heart, liver, kidney diseases or cancer. Non-smokers only (or those who quit over a year ago), not pregnant/nursing, and haven't been exercising regularly.

What is being tested?

The trial is testing the effectiveness of Noom for improving diet adherence during exercise in the morning vs. afternoon for better weight loss and heart health in type 2 diabetics. It's checking if this leads to better blood sugar control and blood pressure.

What are the potential side effects?

Since this study involves lifestyle changes rather than medication, side effects may include typical exercise-related issues such as muscle soreness or fatigue but are generally minimal compared to drug interventions.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am currently on medication that affects my heart rate or rhythm.

Select...

I am between 30 and 70 years old.

Select...

I have been diagnosed with type 2 diabetes.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:

Select...

I have type 1 diabetes and need insulin.

Select...

I am currently on medication to help with weight loss.

Select...

I am currently smoking or quit less than a year ago.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ over the course of 2 weeks.

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~over the course of 2 weeks.

This trial's timeline: 3 weeks for screening, Varies for treatment, and over the course of 2 weeks. for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Body Weight

Secondary study objectives

Flow-mediated dilation

Glucose Tolerance

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Exercise MorningExperimental Treatment2 Interventions

If subjects are randomly assigned to this group, they will participate in exercise training in the morning at a moderate to hard intensity. Subjects will be asked to regularly engage in morning exercise while supervised for about 2 weeks.

Group II: Exercise AfternoonActive Control1 Intervention

If subjects are assigned to this group, they will participate in the same exercise program but after in the afternoon.

0 / 6Eligibility criteria met